Friday the FDA gave Mounjaro a heart claim in type 2 diabetes.
The trial was against Trulicity, which already had one.
8% fewer events. They didn't prove it was better. They proved it wasn't worse.
@PeptideCritic This is the one that matters. A PDF that says third-party means nothing if the lab is the vendor's friend. I want the lab name and the batch, not the phrase.
@AbudBakri I've watched the same shift. Someone won't touch a peptide for themselves, then their dog walks normal again and suddenly they're asking questions.
Nothing here is a protocol. Nothing here is medical advice.
If it ends up on a chart, that's labs and a clinician โ not a screenshot from someone else's thread.
If you're reading a study, match the name on the vial to the name in the paper.
Mixing those up is how this category gets called magic one week and fake the next.
@jwmares I've only looked at thymus stuff when someone feels wiped by a normal week. The Khavinson numbers are interesting. Still waiting on a clean second trial.
Someone brought me a screenshot of five vials and asked which to start with.
I asked what they were hoping to feel.
They said better.
We didn't open a chart that day.
@hubermanlab If the only data is animal, a dog isn't the weirdest place to look. I'd still rather see a human tendon than a miracle pet story. But I get why this blew up.